FABP4 was linked to more aggressive AML through increased IL6 expression, resulting in DNMT1 overexpression and silencing of p15INK4B tumor-suppressor gene in AML cells [138]. The gene discussed is CDKN2B; the disease is acute myeloid leukemia.